Klin Farmakol Farm. 2019;33(4):30-34 | DOI: 10.36290/far.2019.029

Risk minimization and three pillar theory for drugs that inerease the risk of falls

Jiří Vlček1, Sylva Bártlová2, Iva Brabcová2, Martin Doseděl1, Hana Hajduchová2, Aleš Kuběna1, Josef Malý1, Valérie Tóthová2, Jan Vosátka1
1 Univerzita Karlova, Farmaceutická fakulta v Hradci Králové, Katedra sociální a klinické farmacie
2 Jihočeská Univerzita v Českých Budějovicích, Zdravotně sociální fakulta

Falls are adverse events and they can do a harm of patients. Falls are more risky for elderly and about 25 % of visitors to emergency department are as a result of the fall and about one quarter of them are admitted to the medical ward. Fall is an multifactorial event and there are many risk factors influenceable and non-influenceable, internal and external ones. Medicine are part of influenceable risk factors. The goal is to introduce general view on risk minimization management, to explain theory of three pillars in relationship to medicines with fall potential and to of fall and to identify their risk factors. We linked falls to different types of ADR according WHO classification and focussed on medicine specific risk factors of falls. We analysed medicine causing vertigo, confusing, changes of sensoric organs and another pathophysiologic changes to participate in drug related fall. We applied three pillars theory for it.

Conclusions: Specialist for drug related problems needs to know good theory of three pillars of ADR. Good knowledge about pathophysiology of falls and way which tool of drug use is necessary to understand to minimize risk of fall as well. This knowledge can be useful and used for risk minimization algorithm SAFE

Keywords: fall, risk minimization, FRID, drug related problem, theory of three pillars, adverse drug reaction, medicine related risk factors.

Published: January 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlček J, Bártlová S, Brabcová I, Doseděl M, Hajduchová H, Kuběna A, et al.. Risk minimization and three pillar theory for drugs that inerease the risk of falls. Klin Farmakol Farm. 2019;33(4):30-34. doi: 10.36290/far.2019.029.
Download citation

References

  1. Kolektiv autorů: Koncepce oboru klinická farmacie - I. část Česká a slovenská farmacie 2016, Suppl.: S1-S16. Dostupné z: http://www.prolekare.cz/ceska‑slovenska‑farmacie‑archiv‑cisel
  2. Hege THereSe Bell et al. Factors influencing prescribing of fall‑risk‑increasing drugs to the elderly: a qualitative study; Scandinavian Journal of Primary Health Care 2015; 33: 107-114. Go to original source... Go to PubMed...
  3. Ying Chen, et al. Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients; Therapeutics and Clinical Risk Management; 2014; 10: 437-448. Go to original source... Go to PubMed...
  4. Centrální systém hlášení nežádoucích událostí - Metodika Nežádoucí událost PÁD verze 01/2019 [cit. 27. 8. 2019]. Dostupné z: https://shnu.uzis.cz/cs/metodicke‑materialy/pady/
  5. Maartje H, de Groot, et al. The Effects of Fall‑Risk‑Increasing Drugs on Postural Control: A Literature Review; Drugs&Aging 2013; 30(11): 901-920. Go to original source... Go to PubMed...
  6. Harun A, Agrawal Y. The Use of Fall Risk Increasing Drugs (FRIDs) in Patients With Dizziness Presenting to a Neurotology Clinic; Otol Neurotol. 2015; 36(5): 862-864. Go to original source... Go to PubMed...
  7. Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009; 169: 1952-1960. Go to original source... Go to PubMed...
  8. Seppala LJ. Fall‑Risk‑Increasing Drugs: A Systematic Review and Meta‑Analysis: II. Psychotropics J Am Med Dir Assoc. 2018 Apr; 19(4): 371.e11-371.e17. Go to original source... Go to PubMed...
  9. Zia A, et al. The consumption of two or more fall risk‑increasing drugs rather than polypharmacy is associated with falls; Geriatr Gerontol Int 2017; 17: 463-470. Go to original source... Go to PubMed...
  10. Colmenares EW, Pappas AL. Proton Pump Inhibitors: Risk for Myopathy? Ann Pharmacother. 2017; 51(1): 66-71. Go to original source... Go to PubMed...
  11. Maly J, a spol. Analysis of the fall‑related risk of pharmacotherapy in Czech hospitals: a case control study J Appl Biomed 2019; 17(1); 23-60. Go to original source...
  12. Chimirri S, et al. Vertigo/dizziness as a Drugs' adverse reaction J Pharmacol Pharmacother. 2013; 4(Suppl1): S104-S109. Go to original source... Go to PubMed...
  13. Medicine‑induced Vertigo Prescriber Update 2017; 38(1): 12-13.
  14. Škrha J. Hypoglykémie - důležitý fenomén moderní léčby diabetu mellitu; Remedia, 2008; suppl 1; S34-S41.
  15. Moore AR, O'Keeffe ST. Drug‑induced cognitive impairment in the elderly; Drugs Aging. 1999; 15(1): 15-28. Go to original source... Go to PubMed...
  16. Carlos E, Durán, et al. Systematic review of anticholinergic risk scales in older adults; Eur J Clin Pharmacol 2013; 69: 1485-1496. Go to original source... Go to PubMed...
  17. Colmenares EW, Pappas AL. Proton Pump Inhibitors: Risk for Myopathy? Ann Pharmacother. 2017; 51(1): 66-71. Go to original source... Go to PubMed...
  18. Expet analysis Statin intolerance: not a myth; Am Coll Cardiol 2015, www.acc.org/latest‑in‑cardiologyúarticlesú2015/08/11/09/16/statin‑intolerance‑not‑a-myth
  19. Trevisan C, et al. Decision tree for ward admissions of older patients at the emergency department after a fall; Geriatr Gerontol Int 2018; 18(9): 1388-1392. Go to original source... Go to PubMed...
  20. Ramdas WD, et al. Evaluation of risk of falls and orthostatic hypotension in older, long‑term topical beta‑blocker users: Graef Arch Clin Exp 2009; 247(9): 1235-1241. Go to original source... Go to PubMed...
  21. Schatz SN, Weber RJ. Adverse Drug Reactions; in PSAP 2015 CNS/Pharmacy practice edd. by Murphy JE and Lee MW, American collage of clinical pharmacy: 5-26.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.